![]() Myosmine structure
|
Common Name | Myosmine | ||
---|---|---|---|---|
CAS Number | 532-12-7 | Molecular Weight | 146.189 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | 244.7±22.0 °C at 760 mmHg | |
Molecular Formula | C9H10N2 | Melting Point | 42-44°C | |
MSDS | Chinese USA | Flash Point | 101.8±22.3 °C | |
Symbol |
![]() GHS07 |
Signal Word | Warning |
Use of MyosmineMyosmine, a specific tobacco alkaloid in nuts and nut products, has low affinity for a4b2 nicotinic acetylcholinergic receptors (nAChR) with a Ki of 3300 nM[1][2]. |
Name | 3-(3,4-dihydro-2H-pyrrol-5-yl)pyridine |
---|---|
Synonym | More Synonyms |
Description | Myosmine, a specific tobacco alkaloid in nuts and nut products, has low affinity for a4b2 nicotinic acetylcholinergic receptors (nAChR) with a Ki of 3300 nM[1][2]. |
---|---|
Related Catalog | |
Target |
Ki: 3300 nM (a4b2 nAChR) and >10 µM (AT1)[1] |
In Vitro | Myosmine is easily nitrosated, yielding 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB) and the esophageal tobacco carcinogen N'-nitrosonornicotine[2]. |
In Vivo | Myosmine (0.001, 0.005, 0.5, and 50 micromol/kg; oral; in Wistar rats) causes a higher percentage of the radioactivity excreted in urine (86.2% and 88.9%) at the two lower doses (0.001 and 0.005 micromol/kg),as compared with the higher doses (0.5 and 50 micromol/kg), where only 77.8% and 75.4% of the dose is found in urine[2]. |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 244.7±22.0 °C at 760 mmHg |
Melting Point | 42-44°C |
Molecular Formula | C9H10N2 |
Molecular Weight | 146.189 |
Flash Point | 101.8±22.3 °C |
Exact Mass | 146.084396 |
PSA | 25.25000 |
LogP | -0.63 |
Vapour Pressure | 0.0±0.5 mmHg at 25°C |
Index of Refraction | 1.611 |
Storage condition | 2-8°C |
Stability | Moisture, Temperature Sensitive |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
![]() GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn |
Risk Phrases | R22 |
Safety Phrases | S26-S36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | UT7660000 |
HS Code | 2933990090 |
Precursor 8 | |
---|---|
DownStream 8 | |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
A reversed-phase HPLC-UV method developed and validated for simultaneous quantification of six alkaloids from Nicotiana spp.
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 997 , 142-5, (2015) A reversed-phase HPLC-UV method was developed, optimized, and validated for the separation and quantitation of six target alkaloids from leaves of Nicotiana species (nicotine, nornicotine, anatabine, ... |
|
Effects of nicotine and minor tobacco alkaloids on intracranial-self-stimulation in rats.
Drug Alcohol Depend. 153 , 330-4, (2015) While nicotine is the primary addictive compound in tobacco, other tobacco constituents including minor alkaloids (e.g., nornicotine, anabasine) may also contribute to tobacco addiction by mimicking o... |
|
Low-dose nicotine self-administration is reduced in adult male rats naïve to high doses of nicotine: implications for nicotine product standards.
Exp. Clin. Psychopharmacol. 22(5) , 453-9, (2014) Product standards that greatly reduce the content of nicotine within cigarettes may result in improved public health. The study presented here used an animal model to investigate whether individuals w... |
Prestwick_202 |
3-(4,5-dihydro-3H-pyrrol-2-yl)-pyridine |
Pyridine, 3-(1-pyrrolin-2-yl)- |
dehydronornicotine |
3-(3,4-Dihydro-2H-pyrrol-5-yl)pyridine |
Pyridine, 3-(3,4-dihydro-2H-pyrrol-5-yl)- |
MFCD00052019 |
3-(1-Pyrrolin-2-yl)pyridine |
Myosmine |
Pyridine,3-(3,4-dihydro-2H-pyrrol-5-yl) |